|
FAM108A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.73573999999732E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.42950000000675E-05 |
| Normal-vs-Stage2 |
1.295770E-01 |
| Normal-vs-Stage3 |
1.719530E-02 |
| Normal-vs-Stage4 |
4.617800E-01 |
| Stage1-vs-Stage2 |
5.731000E-01 |
| Stage1-vs-Stage3 |
9.190800E-01 |
| Stage1-vs-Stage4 |
4.030000E-01 |
| Stage2-vs-Stage3 |
5.905600E-01 |
| Stage2-vs-Stage4 |
7.158200E-01 |
| Stage3-vs-Stage4 |
4.205400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.00780000000545E-05 |
| Normal-vs-AfricanAmerican |
1.058970E-03 |
| Normal-vs-Asian |
3.476400E-01 |
| Caucasian-vs-AfricanAmerican |
9.944200E-01 |
| Caucasian-vs-Asian |
8.043200E-01 |
| AfricanAmerican-vs-Asian |
7.955000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.1805999999589E-06 |
| Normal-vs-Female |
8.037200E-03 |
| Male-vs-Female |
3.160200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.360400E-03 |
| Normal-vs-Extreme_Weight |
1.64840000005384E-06 |
| Normal-vs-Obese |
4.602400E-03 |
| Normal-vs-Extreme_Obese |
6.894100E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.559000E-01 |
| Normal_Weight-vs-Obese |
7.934200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.245600E-01 |
| Extreme_Weight-vs-Obese |
1.077560E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.166600E-01 |
| Obese-vs-Extreme_Obese |
2.986800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.678260E-02 |
| Normal-vs-Age(41-60Yrs) |
1.234330E-04 |
| Normal-vs-Age(61-80Yrs) |
9.79970000000163E-05 |
| Normal-vs-Age(81-100Yrs) |
8.853400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.754160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.964640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.297800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.717600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.090810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.222020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.88559998118387E-09 |
| Normal-VS-Type2 PRCC |
9.527800E-01 |
| Normal-VS-KIRP CIMP |
3.511400E-01 |
| Normal-VS-Unclassified PRCC |
2.159700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.05019995319833E-09 |
| Type1 PRCC-VS-KIRP CIMP |
1.657580E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.902190E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.827800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.516000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.074800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.402170E-03 |
| Normal-vs-N1 |
1.196190E-01 |
| Normal-vs-N2 |
7.422600E-01 |
| N0-vs-N1 |
6.039200E-01 |
| N0-vs-N2 |
2.141800E-01 |
| N1-vs-N2 |
4.197400E-01 |
|
|
